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Abstract   33 
Purpose: 34 
The aim of our study was to analyse paediatric sight-impairment trends in Northern Ireland (NI) over 35 
a 28-year period to better understand the impact which changes in healthcare provision may be 36 
having on childhood blindness and to enable us to assess our progress towards achieving the World 37 
Health Organisations (WHO) aims. 38 
Methods: 39 
A database of Certificates of Visual Impairment completed for NI children under 16 years old was 40 
used to determine cause of sight-impairment from 1984 to 2011. Causes were classified into 41 
preventable or treatable conditions and analysed for trends. 42 
Results: 43 
598 children were registered as having impaired vision over the 28-year period. 22% had 44 
preventable or treatable conditions. Optic atrophy was the most common cause responsible for 16% 45 
of registrations followed by albinism (12%), cerebral visual impairment (CVI) (11%), congenital 46 
cataract (8%), retinopathy of prematurity (ROP) (8%) and congenital motor nystagmus (CMN) 47 
(7%).The incident rate (per million population under 16 years of age) for registerable vision loss due 48 
to congenital cataract decreased from 5.89 (CI 2.82-10.83) in 1984-1987 to 2.63 (CI 0.72-6.74) in 49 
2008-2011.  For retinopathy of prematurity, the incident rate peaked during 2000-2003 at 8.87 (CI 50 
4.85-14.88).  Thereafter, there was a statistically significant reduction in incident rate to 1.98 (CI 51 
0.41-5.77) in 2008-2011 (p=0.008). 52 
Conclusions:  53 
Sight-impairment registrations due to preventable or treatable causes have decreased over the last 54 
28 years. This is likely due to better surgical techniques and improved refractive care for conditions 55 
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such as congenital cataract and ongoing research and treatment protocols for conditions such as 56 
ROP.  Future advances in this area may help to further reduce the burden of childhood sight-57 
impairment and improve quality of life for these patients. 58 
Main Article 59 
Introduction 60 
Preventable sight-impairment has been a major focus of the World Health Organisation (WHO) for 61 
many years. In 1999, WHO published its initiative for eliminating avoidable blindness, VISION 2020- 62 
The Right to Sight (1). Its vision is a world in which no one is needlessly blind and those with 63 
unavoidable vision loss can achieve their full potential (1). Childhood blindness is one of the priority 64 
eye diseases highlighted in this document. An estimated worldwide prevalence of 1.4 million blind 65 
children confers significant social, economic and emotional impact on society (2). Major focus is on 66 
the preventable or treatable causes which are felt to account for 40% of childhood blindness (3). The 67 
main avoidable causes of visual impairment worldwide are corneal scarring, cataract, glaucoma, 68 
retinopathy of prematurity (ROP) and refractive errors (3). Early treatment of these conditions is 69 
vital to prevent amblyopia and ensure normal visual development (4).  70 
Worldwide, there have been several breakthroughs since the publication of VISION 2020 in relation 71 
to childhood blindness. The United Nations Children’s Fund (UNICEF) estimates significant reduction 72 
in Vitamin A deficiency-related visual impairment due to the implementation of the Vitamin A global 73 
Initiative (3). The Measles initiative has reduced measles related deaths by 28% from 1999 to 2004 74 
and an associated reduction in the incidence of corneal scarring is expected (3).  75 
WHO outlined objectives for 2020 in relation to childhood blindness which include provision of 76 
services to treat children with cataract, glaucoma, ROP and corneal scarring (3). It also states that 77 
optical services to address refractive errors and provision of low vision services should be made 78 
available. 79 
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The aim of our study was to analyse paediatric sight-impairment trends in Northern Ireland (NI) over 80 
a 28-year period to give us a better understanding of the impact which changes in healthcare 81 
provision may have had on childhood sight loss and to enable us to assess our progress towards 82 
achieving the WHO aims for VISION 2020. 83 
Methods 84 
A database with information gathered from Certificates of Visual Impairment completed for NI 85 
residents from 1984 is held by the hospital optometric department of the Belfast Health and Social 86 
Care Trust (BHSCT). The Certificate of Visual Impairment form for Northern Ireland is available for 87 
viewing on the Royal College of Ophthalmologists website. (5) 88 
As the data available after 2011 was incomplete, due to issues with lack of staff to maintain the 89 
database, data was extracted for all patients under 16 years of age who were registered as either 90 
sight-impaired (SI) or severely sight-impaired (SSI) between 1984 and 2011 inclusive. This 91 
information was then entered into and analysed using Microsoft Excel 2007. Of note, data was not 92 
available for 1989 or 1998; again, due to staffing issues impacting on database maintenance.  93 
Full approval was obtained from the Belfast Health and Social Care Trust Standards, Quality and 94 
Audit department and data was managed in accordance with BHSCT current guidance on data 95 
protection. 96 
We adhered to the definitions for sight-impaired and severely sight-impaired as set out by the 97 
Department of Health, Certificate of Visual Impairment: Explanatory notes for Consultant 98 
Ophthalmologists and Hospital Eye Clinic Staff issued in September 2007. (6). This document defines 99 
severe sight-impairment as Snellen visual acuity less than 3/60, or visual acuity between 3/60 and 100 
6/60 with a very contracted field of vision, or visual acuity above 6/60 but contracted field of vision 101 
especially inferiorly. In our paediatric population, equivalent visual acuity measurements using other 102 
optotypes were valid, or if visual acuity could not be measured formally, clinical features of visual 103 
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defects (eg. not fixing or following to light) were included but classified as sight-impaired. The 2007 104 
Department of Health document defines sight-impairment as Snellen visual acuity between 3/60 and 105 
6/60 with full field, visual acuity up to 6/24 with moderate field contraction, opacities in the media 106 
or aphakia, or visual acuity of 6/18 or better with marked field contraction (6). We appreciate that 107 
these definitions do not directly correlate with the WHO 2016 ICD-10 definitions of mild, moderate 108 
and severe visual impairment and blindness (7). 109 
However, as we analysed data from Certificates of Visual Impairment, we felt it was appropriate to 110 
present this data using the Department of Health Certificate of Visual Impairment definitions of 111 
sight-impairment and severe sight-impairment. 112 
Based on the information on the cause of reduced vision in each patient, we classified aetiology 113 
using a dual taxonomy described by Rahi et al (8). The causes were classified in two ways: by 114 
individual disorders, grouped by the anatomical site affected, and by timing of specific causal factors 115 
leading to vision loss.  116 
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We further classified the individual disorders causing sight loss into preventable or non-preventable 117 
and treatable or non-treatable based on current understanding with a view to identifying the 118 
proportion of avoidable vision loss in our study population.  119 
Looking at the sight-impaired and severe sight-impaired registrations as a whole, the six leading 120 
causes of reduced vision were identified for our NI population. For every 4-year period between 121 
1984 and 2011, we identified the number of registrations for each condition and estimated the 122 
annual incident rates per million population under 16 years of age. In the periods which included 123 
one year of missing data (1988-1991 and 1996-1999), incident rates were computed using the 124 
available information (3 years in each case). 95% confidence intervals were computed for the 125 
incidence rates assuming a Poisson distribution model. In comparisons between periods, statistical 126 
significance of differences in incidence rates was assessed using Fisher’s exact test. Poisson 127 
regression model analysis was used to check for trends in incidence rates over the seven 4-year 128 
periods. Differences and trends in incidence rates with a p value of less than 0.05 were considered 129 
statistically significant. Analysis was performed using MATLAB® 9.1 (R2016b). 130 
 131 
Results 132 
Five hundred and ninety-eight children were registered as having impaired vision over the 28-year 133 
period (Figure 1). Two hundred and thirty-four (39%) were registered as sight-impaired and three 134 
hundred and sixty-four (61%) were registered as severely sight-impaired. 53% were males and 26% 135 
had associated systemic conditions (table 1). The mean age at registration was 7.4 years (SD± 4.6 136 
years) with a range of 2 months to 16 years. Three of these patients had no cause of sight-137 
impairment documented on their registration forms and were therefore excluded from further 138 
analysis. 139 
The timing of the insult was prenatal in 69% (of which 77% were hereditary/congenital), 140 
perinatal/neonatal in 22%, and occurred during childhood in 9% (Table 2). Three hundred and fifty-141 
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seven cases (60%) were neither preventable nor treatable. Of the remaining 238 cases, 132 (22%) 142 
were considered either preventable or treatable and 104 (18%) were considered to be possibly 143 
preventable or treatable (Table 3). 144 
Anatomically, the majority (37%) of registrations for impaired vision were due to retinal disorders. 145 
Only 31% of these 218 patients with retinal pathology had potentially preventable/treatable causes 146 
such as ROP or Autosomal Dominant Retinal Dystrophy. 147 
Overall the most common cause of vision loss was optic atrophy (16%); of these 39% were primary 148 
optic atrophy and 61% had secondary optic atrophy. The subsequent five main causes in order after 149 
optic atrophy were, albinism (12%), cerebral visual impairment (CVI) (11%), congenital cataract (8%), 150 
retinopathy of prematurity (ROP) (8%) and congenital motor nystagmus (CMN) (7%).   151 
When we analyse the incident rates for the six leading causes of all registrations (sight-impaired and 152 
severe sight-impaired) in Northern Ireland for each 4-year period from 1984-2011, we can identify 153 
some interesting trends in both the preventable/treatable conditions and also the non-154 
preventable/non-treatable conditions (Figure 2). 155 
Incident rates for optic atrophy and albinism fluctuate over the years but there was no significant 156 
change between 1984-1987 and 2008-2011 for either condition (p for trend = 0.88 and 0.94, 157 
respectively). This reflects the fact that visual loss due to either optic atrophy or albinism can neither 158 
be prevented nor treated. 159 
Cerebral visual impairment as a cause for registration shows a general upward trend over the last 28 160 
years. The incident rate increased from 1.77 per million (CI 0.36-5.16) in 1984-1987 to 12.51 per 161 
million (CI 7.53-19.54) in 2008-2011.  This 7-fold increase was statistically significant (p for trend 162 
<0.0001). 163 
Congenital motor nystagmus also shows a significant upward trend with an incident rate of 0.59 per 164 
million (CI 0.01-3.28) in 1984-1987 increasing to 8.87 per million (CI 4.85-14.88) in 2000-2003 (p for 165 
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difference =0.0003); at which point, it dramatically reduces to 0.66 per million (CI 0.02-3.67) in 2008-166 
2011 (p for difference=0.0006).  167 
The two main preventable/treatable causes of paediatric vision loss which show interesting trends 168 
over the last 28 years are congenital cataract and retinopathy of prematurity which together are 169 
responsible for 16% of reported sight-impairment and severe sight-impairment. 170 
The incident rate for congenital cataract decreased from 5.89 per million (CI 2.82-10.83) in 1984-171 
1987 to 2.63 per million (CI 0.72-6.74) in 2008-2011.  This 2-fold decrease in registered vision loss 172 
due to congenital cataract failed to reach statistical significance (p for trend =0.053). 173 
The incident rate for retinopathy of prematurity reduced from 5.30 per million (CI 2.42-10.06) in 174 
1984-1987 to 0.80 per million (CI 0.02-4.45) in 1988-1991 (p for difference=0.03) but peaked again 175 
during 2000-2003 with an incident rate of 8.87 per million (CI 4.85-14.88).  Thereafter, there was a 176 
statistically significant reduction in incident rate to 1.98 per million (CI 0.41-5.77) in 2008-2011 (p for 177 
difference=0.008). 178 
Discussion 179 
The Northern Ireland (NI) Statistics and Research Agency reported a paediatric population (< 16-180 
year-old) of 379 323 following the 2011 NI Census (9). We identified 21 new cases of children 181 
registered with impaired sight in 2011; giving an annual incidence of 0.55 per 10 000 (CI 0.34-0.84).  182 
Of these 21 children, 13 were registered as severely sight-impaired giving an incidence of blind 183 
registrations of 0.34 per 10 000 (CI 0.18-0.58) in 2011 in children under 16 years of age which is 184 
comparable to Mitry et al’s reported annual incidence of new blind registrations of 0.41 per 10 000 185 
in 2011 in children under 17 years of age in a similar study conducted in England (10).  186 
A 1976 Northern Ireland population study by Bryars and Archer, identified genetic disease and birth 187 
hypoxia as the leading causes of significant sight-impairment (11). This finding has been replicated in 188 
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the current study with 56% of severely sight-impaired children having perinatal hypoxia or 189 
hereditary/congenital causal factors recorded on their registration forms.  190 
Avoidable causes of blindness have been given priority by the WHO organisation and retinopathy of 191 
prematurity is recognised as one of those conditions. ROP contributed to 8% of all registrations in 192 
our overall study population but there were significant fluctuations over time. Our study data 193 
extends back to 1984 and the first significant change in incident rate for vision loss secondary to ROP 194 
occurred between 1984-1987 and 1988-1991 when there was a 6.6-fold reduction in incident rate 195 
(CI 0.92-291.06, p for difference=0.03). This decline coincided with the publication of the results of 196 
the CRYO-ROP trial in early 1988. This large multicentre trial demonstrated that those neonates with 197 
threshold ROP treated with cryotherapy had a significantly lower rate of adverse outcome compared 198 
to those untreated (21.8% vs 43%) (12). This study clearly impacted on the visual outcome of 199 
neonates with ROP as demonstrated by our findings. As the percentage of preterm babies surviving 200 
annually continued to increase and the survival rate for those born at extremely low gestational age 201 
(less than 26 weeks) continued to improve with advancing neonatal care, the rate of sight-202 
impairment attributable to ROP in NI steadily increased after 1988-1991 (13) (14). With the hope of 203 
further lowering the rate of adverse outcomes, the National Eye Institute put together a 204 
collaborative group to study earlier treatment for ROP (ETROP), the results of which were published 205 
in 2003 (15). The ETROP study was pivotal in highlighting the importance of early ablative therapy in 206 
improving visual outcomes for patients with high risk ROP. Our study demonstrates coinciding 207 
positive effects on childhood vision with the incident rate for vision loss due to ROP falling from its 208 
highest level of 8.87 per million during 2000-2003 to 1.98 per million in 2008-2011. The adoption of 209 
the ETROP recommendations for earlier treatment of ROP was also reflected in the reported 210 
increase in ROP treatments in Northern Ireland with the percentage of ‘at risk’ infants surviving to 42 211 
weeks gestational age requiring ROP treatment increasing from 1% in 2000 to 5.8 % in 2011 (14). 212 
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The most common treatable cause of vision loss in our population was cataract (8% of all 213 
registrations) which also demonstrated an interesting trend with incident rates decreasing by 50% 214 
over the 28-year period. At the start of our study, congenital cataracts were responsible for 14% of 215 
the 72 registrations during 1984-7 which gradually declined to 5% of the 84 registrations during 216 
2008-11 (Figure 2). This is comparable to the findings of a large study performed by the British 217 
Childhood Visual Impairment Study Group (BCVISG) which also reported 5% of severe visual 218 
impairment to be caused by cataract in 2000 (8).  219 
Although the incidence of congenital cataract is relatively low in developed countries such as the 220 
United Kingdom (UK), it remains the leading cause of surgically correctable blindness worldwide 221 
(16). In the UK, during the 1960s and 1970s, UK child health surveillance programmes began to 222 
develop which recognised the importance of vision screening in children. By the late 1980s, these 223 
programmes were being rationalised and more robust screening programmes for pre-school children 224 
were established (17).  Newborn screening should now occur within the first 72 hours after birth and 225 
between 6 and 8 weeks of age to identify any abnormality of the red reflex (18). This early detection 226 
of cataract is vital in providing timely treatment for what is an extremely amblyogenic condition. 227 
Although it did not reach statistical significance, the observed downward trend in vision loss due to 228 
cataract may possibly be explained by this early detection in addition to improved surgical 229 
techniques and refractive aftercare (16).  230 
Cerebral visual impairment (CVI) as a cause for registerable visual loss demonstrated a 7-fold 231 
increase in incident rate between 1984-1987 and 2008-2011. This is now one of the main causes of 232 
impaired vision in our population and although it is not treatable or reversible it should be a focus of 233 
study and investment to reduce the impact on patient quality of life. This increase in CVI may be 234 
explained by the improvement in neonatal care for the premature or disabled child, resulting in 235 
increased survival rates. The proportion of premature neonates has not significantly increased over 236 
the last 28 years (19). However, the survival rate of these preterm infants has greatly improved due 237 
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to the improved neonatal care. In the UK and Wales, neonatal mortality rate fell by 60% from 7.7 238 
deaths per 1000 live births in 1980 to 3.1 deaths per 1000 live births in 2009 (20). This along with 239 
increased awareness and reporting are possible explanations for the significant increase in reported 240 
cases of CVI. 241 
Another interesting trend which may reflect the effect of improved diagnostic investigations is the 242 
observed changes in incident rates in congenital motor nystagmus and albinism over the last decade. 243 
In 2004-2007, the incident rate for registration due to congenital motor nystagmus was 7.26 per 244 
million (CI 3.63-13.00) which decreased to 0.66 per million (CI 0.02-3.67) in 2008-2011 (p for 245 
difference =0.003).  This decrease coincided with an increase in the incident rate for registrations 246 
due to albinism from 3.96 per million (CI 1.45-8.62) in 2004-2007 to 7.24 per million (CI 3.62-12.96) 247 
in 2008-2011 (p for difference=0.17).   248 
Foveal hypoplasia has long been recognised as an associated feature of albinism, even in mild cases, 249 
but is not evident in patients with congenital motor nystagmus (21). With improved availability of 250 
optical coherence tomography, foveal hypoplasia is now a much more easily identified feature. In 251 
turn, children who were once diagnosed as having congenital motor nystagmus may be now more 252 
correctly diagnosed as having ocular albinism. 253 
Our patient cohort is population-based. According to migration statistics, immigration in NI is greater 254 
than emigration making Northern Ireland an ideal population for epidemiological studies. Our study, 255 
like other published studies on paediatric sight-impairment, analysed data from registration 256 
databases which are largely non-compulsory and therefore may not have captured all children with 257 
significant sight-impairment. A further limitation of our study, was the lack of data collection for 258 
1989 and 1998 due to staffing issues. We also recognise that the concept of childhood sight-259 
impairment has changed over the last 3 decades and ‘blind’ registers do not comprehensively 260 
capture all children with complex visual needs (22). 261 
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The data is useful, however, as a minimum estimate and can provide useful indication of trends.  262 
This study demonstrates the positive impact improvements in healthcare and disease prevention can 263 
have on the quality of life of our paediatric population. In line with the aims of VISION 2020, the 264 
implementation of effective screening and treatment protocols for preventable and treatable 265 
conditions has resulted in a decreasing trend in some of our leading causes of paediatric sight-266 
impairment. Future advances in therapies for genetic ophthalmic disorders may help to further 267 
reduce the burden of childhood sight-impairment due to currently non-treatable and non-268 
preventable conditions such as albinism and hereditary optic atrophy.  269 
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Table 1: Demographic details, associations and timing of insult for severely sight-impaired 
and sight-impaired children. 
 
 Severely sight 
impaired (n=364) 
Sight impaired 
 (n=234) 
Overall 
(n=598) 
Gender  
Male 
Female 
Unknown 
 
181 
181 
2 
 
134 
98 
2 
315 
279 
4 
Age 
<1 
1-4 
5-15 
Unknown 
 
20 
121 
212 
11 
1 
48 
176 
9 
21 
169 
388 
20 
Positive Family History 
of condition 
39 (11%) 32 (14%) 71 (12%) 
Known associated 
Systemic/syndromic 
condition  
125 (34%) 28 (12%) 153 (26%) 
Time of insult 
Prenatal 
Perinatal/Neonatal 
Childhood 
Unknown 
 
222 (61%) 
110 (30%) 
30 (8%) 
2 (1%) 
187 (80%) 
19 (8%) 
27 (11%) 
1 (1%)
409 (68%) 
129 (21%) 
57 (10%) 
3 (1%) 
 
Table 2: Causal factors categorised into time of insult. 
 
 Severely sight 
impaired (n=362) 
Sight impaired
(n=233) 
Overall 
(n=595) 
Prenatal 
Hereditary/congenital 
Infection 
Other 
n=222 
153 
4 
65 
n=187 
163 
2 
22 
 
316 
6 
87
Perinatal/Neonatal 
Hypoxia/Ischemia 
Infection 
Hydrocephalus 
Other 
n=110 
50 
2 
10 
48 
n=19 
3 
0 
5 
11 
 
53 
2 
15 
59 
Childhood 
Tumour 
Infection 
Refractive 
Accidental injury 
Systemic disorders 
Other 
n=30 
12 
2 
4 
1 
6 
5 
n=27 
5 
0 
12 
1 
4 
5 
 
17 
2 
16 
2 
10 
10 
 
Table 3: Potentially preventable or treatable causes. 
 
 Number of children (n=595)
Preventable 
Retinopathy of prematurity 
Prenatal Rubella 
Total=50 (8%)
48 
2 (cataracts) 
Possibly Preventable 
 
Autosomal Dominant Conditions 
 -Aniridia 
 -Retinal dystrophy 
 -Primary optic atrophy 
 -Congenital glaucoma 
 -Congenital Cataract 
 -Retinoblastoma 
 -Other 
Trauma 
Total=44 (7%)
 
 
2 
11 
9 
2 
11 
2 
5 
2
Treatable 
Refractive error 
Uveitis 
Glaucoma 
Ectopia lentis 
Cataract 
Retinal detachment 
Retinoblastoma 
Meningitis 
Infection 
Total= 82 (14%)
17 
3 
15 
7 
32 
2 
4 
1 
1 
Possibly treatable 
Hydrocephalus 
Tumour 
Toxoplasmosis 
Other 
Total=62 (10%)
21 
18 
5 
18 
Not treatable or preventable Total= 357 (60%)
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Albinism Nystagmus Optic Atrophy
(a) ROP, Cataract & CVI
(b) Albinism, Congenital Nystagmus & Optic Atrophy
